Evaluation of microaneurysms using intravitreal faricimab for diabetic macular edema

Evaluation of microaneurysms using intravitreal faricimab for diabetic macular edema - Evaluation of microaneurysms using intravitreal faricimab for diabetic macular edema

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000049521

Enrollment

Registered

2022-11-16

Start date

2022-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetic macular edema

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who received farisimab for DME from the Department of Ophthalmology, University of Fukui Hospital between August 1, 2022 and December 31, 2024

Exclusion criteria

Exclusion criteria: Patients who refused to be enrolled in this study. Patients who were unable to undergo ophthalmologic examination due to cognitive or physical factors. Other cases in which the principal investigator determines that the patient is inappropriate as a research subject.

Design outcomes

Primary

Measure	Time frame
Changes in the number of microaneurysms	—

Countries

Japan

Contacts

Public Contactyutaka yamada

university of Fukui Hospital Ophthalmology

yyutaka@u-fukui.ac.jp0776-61-8403

Outcome results